-S.P.Chopra (theimagestar@gmail.com)
New Delhi : Planning and opting
for IVF pregnancy is a stressful and emotional task for every couple. There are
various factors that contribute to IVF failures and one of the most important
factors is window of implantation. Researchers in a study have suggested that
if a woman is unable to achieve pregnancy even after repeated IVF treatments
there is a possibility that these treatments are being performed in the “wrong
window of implantation”. About 28% of the IVF cycles are done on the wrong day.
In an IVF treatment, the focus is usually on the quality of the
embryos, looking for the ones which are more likely to result into a successful
pregnancy after transferring them to the uterus. But in this process, the
function of the endometrium, the lining of the uterus which houses the embryo
allowing for its implantation, is often forgotten. For successful implantation
the lining of the uterus (endometrium) is equally important as the quality of
embryos.
Endometrium is the inner lining which is prepared every month to
accept the embryo, indeed this is the area where the embryo implants and stays
during gestation. Embryo implantation can only be successful if it is carried
out between 19-21 days of the menstrual cycle. This is the window of
implantation. It is the personalized timing that’s unique and specific
for each woman. There are many couples who are deprived of the joy of
parenthood due to a displaced window of implantation.
To help the couples who are suffering from regular implantation
failures, Igenomix has introduced a patented test named Endometrial Receptivity
Analysis (ERA), after 10 years of research in this field. ERA has given hope to
the couples who want to conceive through assisted reproductive technique. ERA
is a state of art diagnostic method evaluating the endometrial receptivity and
is performed using NGS technology.
ERA determines if the woman is receptive or not, on the day when
the biopsy is performed. If the result is positive then that is the window of
implantation for that particular patient. Therefore ERA is a personalised
genetic test that leads to a “personalised embryo transfer” (PET), a timing
based on the test performed on an individual. If the result of the test is
negative then a second biopsy is suggested to validate the displacement.
No comments:
Post a Comment